High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$19.7M
$19,738,855
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $191,900 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $57,780 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $115,882 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,222,696Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,222,696Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,600,549Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,600,549Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $225,087 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,336,722Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,336,722Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $466,244 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,243,091Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,243,091Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,729,166Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,729,166Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 SellΔOwn -12.8%
2026-02-27
$7,718,020Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 SellΔOwn -12.8%
|
2026-02-27 | $7,718,020Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$2,974,479Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $2,974,479Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $857,239 | S | Form 4 |